{"id":19567,"date":"2022-03-23T19:10:00","date_gmt":"2022-03-23T19:10:00","guid":{"rendered":"https:\/\/www.accu-mold.com\/steven-bagshaw\/"},"modified":"2022-03-23T19:10:00","modified_gmt":"2022-03-23T19:10:00","slug":"steven-bagshaw","status":"publish","type":"post","link":"https:\/\/www.accu-mold.com\/fr\/steven-bagshaw\/","title":{"rendered":"Hot Tech (MedTech UK): Next-Gen Wearables"},"content":{"rendered":"\n

Medical Technology UK<\/a> took place in Coventry, England this year at the world-famous Coventry Building Society Arena<\/em>. The event attracts the best minds in medical device engineering. In this special \u201chot tech\u201d section, we highlight exciting research, people, and technology shaping the future of the industry. We caught up with Steven Bagshaw, Head of Business Strategy, CPI<\/em>. <\/p>\n\n\n\n

Do you, or does your company have some hot tech to share? Get in touch!<\/a><\/em><\/p>\n\n\n\n

<\/div>\n\n\n\n

Q&A With Steven Bagshaw, Head of Business Strategy at CPI<\/h2>\n\n\n\n

Bagshaw spoke on challenges in commercializing next-generation wearables at MedTech UK, focusing on the convergence of MedTech and consumer electronics. This Q&A has been lightly edited for clarity.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Q: What barriers are you seeing as the line between wearables and MedTech blurs? <\/strong><\/h3>\n\n\n\n

Most wearables on the market are \u2018HealthTech\u2019 \u2013 i.e. for indication only and not producing medically valid data. MedTech requires any output from wearables to be clinically validated against the gold standard. A good example of this is the use of photoplethysmography (PPG) to derive blood pressure. There are now devices on the market that claim to measure blood pressure, but until these are validated against clinically accepted methods, they will not be accepted by governing bodies, such as the British and Irish Hypertension Society. <\/p>\n\n\n\n

Getting consumers to accept the cost\/functionality difference between \u2018HealthTech\u2019 and \u2018MedTech\u2019 will always be more expensive due to the additional documentation\/standards to be in compliance with. Also, testing, traceability, and\/or manufacturer ISO 13485 accreditation.<\/p>\n\n\n\n

There seems to be more of a focus on wearables for the mass market, rather than dedicated MedTech R&D to provide the tools needed in non-invasive preventative medicine.<\/p>\n\n\n\n

The MedTech R&D community generally has very poor interaction levels with end-users, whether they are patients, clinicians, or a mixture. This does not allow for high-quality user-centered design to be carried out, whereas for the mass market and \u2018HealthTech\u2019 the designers have easy access to large sample groups, particularly in the sports\/exercise industries.<\/p>\n\n\n\n

There are many areas of wearable that are almost impossible for smaller companies to compete in (here<\/a> and here<\/a>) so they not only have to find opportunities outside of these but also face the challenge of having to try to develop MedTech based on a much smaller amount of previous research. <\/p>\n\n\n\n

<\/div>\n\n\n\n

Q: What low-hanging fruit exists in the wearable and MedTech space? <\/strong><\/h3>\n\n\n\n

A few things here:<\/p>\n\n\n\n